-
3 Nature publications in the last 5 months for Optiscan technology
-
2 x China Tender Success for FIVE2 (ViewnVivo)
Announcements -
Read more about our oral cancer trial with Melbourne Dental School in University of Melbourne’s Pursuit magazine
-
Government grant to support Melbourne Dental School Oral Cancer Trial
Announcements -
New publication in Nature’s- Scientific Reports from Memorial Sloan Kettering Cancer Center researchers using Optiscan’s FIVE2 (ViewnVivo)
-
Optiscan Chairman Darren Lurie presents to Chinese distributors and health care professionals in today’s webinar: Zhejiang Overseas Online Matchmaking Conference Life Sciences & Healthtech; Australia Session
-
Optiscan’s North American distributor Scintica Instrumentation’s webinar on Fluorescence In Vivo Endomicroscopy: Imaging and Analysis
-
Carl Zeiss’s virtual launch of its new pathology platform for ZEISS CONVIVO on Monday 22 June 2020
-
Achievement of Final Milestone in Co-operation Agreement with Carl Zeiss Meditec
Announcements -
Optiscan Quarterly Activities & Cashflow Report Quarter Ended 31 March 2020
-
Corporate Update – Additional Cash Receipts Expected
Announcements -
Leading medical research journal publishes study validating OptiScan’s technology